Evidence map›Paper›PMID 27077358›Full record

Trial reportAmerican journal of public health2016

Diffusion of an Evidence-Based Smoking Cessation Intervention Through Facebook: A Randomized Controlled Trial.

Nathan K Cobb, Megan A Jacobs, Paul Wileyto, Thomas Valente, Amanda L Graham

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of public health, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Internet-based interventions for smoking cessation.The Cochrane database of systematic reviews · 2017
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nathan K CobbNathan K. Cobb is with the Department of Pulmonary and Critical Care, Georgetown University Medical Center, Washington, DC, and the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Megan A. Jacobs is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC. Paul Wileyto is with the Department of Biostatistics & Epidemiology, University of Pennsylvania School of Medicine, Philadelphia. Thomas Valente is with the Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles. Amanda L. Graham is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, and the Department of Oncology, Georgetown University Medical Center/Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC.
Megan A JacobsNathan K. Cobb is with the Department of Pulmonary and Critical Care, Georgetown University Medical Center, Washington, DC, and the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Megan A. Jacobs is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC. Paul Wileyto is with the Department of Biostatistics & Epidemiology, University of Pennsylvania School of Medicine, Philadelphia. Thomas Valente is with the Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles. Amanda L. Graham is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, and the Department of Oncology, Georgetown University Medical Center/Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC.
Paul WileytoNathan K. Cobb is with the Department of Pulmonary and Critical Care, Georgetown University Medical Center, Washington, DC, and the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Megan A. Jacobs is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC. Paul Wileyto is with the Department of Biostatistics & Epidemiology, University of Pennsylvania School of Medicine, Philadelphia. Thomas Valente is with the Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles. Amanda L. Graham is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, and the Department of Oncology, Georgetown University Medical Center/Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC.
Thomas ValenteNathan K. Cobb is with the Department of Pulmonary and Critical Care, Georgetown University Medical Center, Washington, DC, and the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Megan A. Jacobs is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC. Paul Wileyto is with the Department of Biostatistics & Epidemiology, University of Pennsylvania School of Medicine, Philadelphia. Thomas Valente is with the Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles. Amanda L. Graham is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, and the Department of Oncology, Georgetown University Medical Center/Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC.
Amanda L GrahamNathan K. Cobb is with the Department of Pulmonary and Critical Care, Georgetown University Medical Center, Washington, DC, and the Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Megan A. Jacobs is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC. Paul Wileyto is with the Department of Biostatistics & Epidemiology, University of Pennsylvania School of Medicine, Philadelphia. Thomas Valente is with the Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles. Amanda L. Graham is with the Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC, and the Department of Oncology, Georgetown University Medical Center/Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC.

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Online Social Networks for Dissemination of Smoking Cessation InterventionsR01CA155369 · NCI · TRUTH INITIATIVE FOUNDATION · PI GRAHAM, AMANDA L · 2011 to 2013
$1.1M
NCI NIH HHS P30 CA016520NCI NIH HHS R01 CA155369
6 · The paper itself

Abstract

objectivesTo examine the diffusion of an evidence-based smoking cessation application ("app") through Facebook social networks and identify specific intervention components that accelerate diffusion.

methodsBetween December 2012 and October 2013, we recruited adult US smokers ("seeds") via Facebook advertising and randomized them to 1 of 12 app variants using a factorial design. App variants targeted components of diffusion: duration of use (t), "contagiousness" (β), and number of contacts (Z). The primary outcome was the reproductive ratio (R), defined as the number of individuals installing the app ("descendants") divided by the number of a seed participant's Facebook friends.

resultsWe randomized 9042 smokers. App utilization metrics demonstrated between-variant differences in expected directions. The highest level of diffusion (R = 0.087) occurred when we combined active contagion strategies with strategies to increase duration of use (incidence rate ratio = 9.99; 95% confidence interval = 5.58, 17.91; P < .001). Involving nonsmokers did not affect diffusion.

conclusionsThe maximal R value (0.087) is sufficient to increase the numbers of individuals receiving treatment if applied on a large scale. Online interventions can be designed a priori to spread through social networks.

Indexed as

Diffusion of InnovationHealth PromotionSmoking CessationSocial MediaAdultEvidence-Based PracticeFemaleHumansInternetMale

Identifiers

PMID27077358
PMCPMC4880261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.